MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Magnetic resonance imaging(MRI)"

  • 2018 International Congress

    Improvements of tremor control and life quality of refractory essential tremor patients after MR-guided focused ultrasound thalamotomy – A Taiwan experience

    H.C. Lai, K. Tsai, W.C. Chang, T. Taira, C.Y. Wei (Changhua County, Taiwan)

    Objective: To quantify the tremor control and life quality changes of refractory essential tremor (ET) patients after the MR-guided focused ultrasound (MRgFUS) thalamotomy in Taiwan.…
  • 2018 International Congress

    Acute concomitant presentation of chorea and subacute combined degeneration secondary to vitamin B12 deficiency

    E. Natera, F. Acebrón, A. Sánchez, V. Ros, A. Gómez, F. Ruiz, B. Zarza, C. Estévez, A. Alonso, JC. Martínez-Castrillo, I. Corral (Madrid, Spain)

    Objective: To describe an exceptional presentation of vitamin B12 deficiency. Background: Vitamin B12 deficiency typically presents with subacute combined degeneration (SCD). Extrapyramidal symptoms are rare,…
  • 2018 International Congress

    Longitudinal changes in Neuromelanin MRI Signal in Parkinson’s Disease

    R. Gaurav, N. Pyatigorskaya, C. Ewenczyk, R. Valabregue, K. Evans, I. Arnulf, M. Vidailhet, S. Lehéricy (Paris, France)

    Objective: To examine the longitudinal changes in neuromelanin (NM) MRI signal in the substantia nigra (SN) in Parkinson’s disease (PD). Background: PD is characterized by…
  • 2018 International Congress

    In vivo MRI signatures of hippocampal subfield pathology in patients with Parkinson’s disease and psychosis

    A. Lenka, M. Ingalhalikar, A. Shah, J. Saini, S. Hegde, A. Shyam Sundar, R. Yadav, P. Pal (Bangalore, India)

    Objective: To study the role of hippocampal subfield pathology in the genesis of psychotic symptoms in patients with Parkinson's disease (PD) by comparing the volumes…
  • 2018 International Congress

    Freezing of gait recognition in Parkinson’s disease: A subject independent objective method

    V. Rama Raju (Hyderabad, India)

    Objective: In this study, we aim to build an automated-FoG-detector for subject-independent. After extracting enormously relevant features, we apply variance detection-techniques to identify-FoG-events. Background: Gait…
  • 2018 International Congress

    Broad White Matter Impairment in Multiple System Atrophy: A case for Oligodendrocyte Dysfunction

    N. del Campo, O. Phillips, F. Ory-Magne, M. Galitzky, C. Brefel-Coubron, C. Thalamas, K. Narr, S. Joshi, M. Singh, P. Péran, A. Pavy-LeTraon, O. Rascol (Toulouse, France)

    Objective: The main objective of this study was to investigate if there are widespread white matter abnormalities in multiple system atrophy (MSA). Background: MSA differs…
  • 2018 International Congress

    A Study on Combined Brain Positron Emission Tomography (PET) – Magnetic Resonance Imaging (MRI) Using Fluorodeoxyglucose (18FDG) (FDG-PET/MRI) in Premanifest Huntington’s Disease Gene-expansion Carriers

    M. Hellem, T. Vinther-Jensen, C. Hansen, E. Budtz-Jørgensen, L. Hjermind, I. Law, J. Nielsen (Copenhagen, Denmark)

    Objective: By a combined brain PET–MRI using FDG, we wished to simultaneously characterize the structural and metabolic brain changes in premanifest HD gene-expansion carriers. Background:…
  • 2018 International Congress

    White Matter Hyperintensities and Mortality among Patients with Parkinsonism in Olmsted County, MN (1995-2010)

    J. Yu, R. Brown, J. Huston, M. Mielke, C. stang, P. Turcano, R. Savica (Rochester, MN, USA)

    Objective: To examine white matter hyperintensity grade (WMHG) by parkinsonism type, and the association between WMHG and mortality among incident parkinsonism patients in a population-based…
  • 2018 International Congress

    Complementary value of MRI-based differential diagnosis in parkinsonism

    S. Kim, E. Oh, Y. Lim, J. Ham, J. Lee, E. Sohn, A. Lee (Daejeon, Republic of Korea)

    Objective: We aimed to evaluate the complementary diagnostic values of MRI characteristics to differentiate various types of parkinsonism. Background: Although precise differential diagnosis of parkinsonism…
  • 2018 International Congress

    Decreased amyloid-beta in patients with Idiopathic Parkinson’s Disease and white matter hyperintensities

    I. Markaki, S. Klironomos, P. Svenningsson (Stockholm, Sweden)

    Objective: The aim of this study is to investigate the clinical and biochemical profile of patients with PD with and without WMH. Background: Parkinson’s disease…
  • « Previous Page
  • 1
  • …
  • 47
  • 48
  • 49
  • 50
  • 51
  • …
  • 72
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25128 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley